To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases

Last updated: May 5, 2024
Sponsor: HoHo Biotech
Overall Status: Active - Recruiting

Phase

2

Condition

Inflammation

Treatment

Hydrogen capsules

Clinical Study ID

NCT06401785
C202305150
  • Ages 20-80
  • All Genders

Study Summary

The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the possible efficacy and safety of solid hydrogen supplements for a clinical study in patients with chronic diseases. Patients will receive hydrogen capsules with their conventional treatment for 24 weeks. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 20 to 80
  • Able to compliant with the protocol
  • Able to return to the hospital regularly
  • Patients with chronic inflammation, including patients with autoimmune diseases,metabolic-related diseases, chronic kidney disease or nephritis, tumor patients, etc.

Exclusion

Exclusion Criteria:

  • Pregnancy
  • Expected pregnancy
  • Attending other clinical trials with 6 months

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Hydrogen capsules
Phase: 2
Study Start date:
May 11, 2024
Estimated Completion Date:
January 29, 2025

Study Description

Hydrogen supplement has been shown to have significant removing effects on free radicals. International clinical trials have shown promise that hydrogen molecules may reduce chronic inflammatory and then speed up recovering the course of the disease.The purpose of this study is to determine the possible efficacy and safety of hydrogen supplements in different formula and dose exposures for a clinical study in patients with chronic diseases.Study design: 60 chronic diseases patients will be recruited from the Taoyuan Armed Forces General Hospital and Tri-Service General Hospital for this study. Participants will be screened by doctors for their eligibility and undergo a series of tests (questionnaires and examinations).Consenting participants will then be randomly allocated into 2 groups (experiment group and control group, single-blind study). In experiment group, participants will receive 2 solid hydrogen capsules every day for 24 weeks. In control group, participants will receive 2 capsules not containing hydrogen every day for 24 weeks. Participants will be examined their regular haematology, urine and health status before and after the intervention.

Connect with a study center

  • Tri-Service General Hospital

    Taipei,
    Taiwan

    Active - Recruiting

  • Taoyuan Armed Forces General Hospital

    Taoyuan,
    Taiwan

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.